title: Pharma R&D set to endure despite rising MFN costs
source: Yahoo
date: 2025-10-10
url: https://finnhub.io/api/news?id=aaa0c0415ce62ca3f9389f8fed23f7b7a7850f8d9244dd03810972f57bf3f9cd
MFN-driven drug price reductions are unlikely to impact pharma R&D spending.
